The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Nagoya Journal of Medical Science
Open accessAbstract
Whole-exome and whole-genome sequencing have become widespread in approximately the last 15 years, and the predisposing factors and pathomechanisms of inflammatory keratinization diseases, which have been unknown for a long time, have gradually been revealed.Hence, various inflammatory keratinization diseases are recognized to cause innate immunity hyperactivation.Therefore, we have been advocating for the clinical entity, "autoinflammatory keratinization diseases (AiKDs)" since 2017.AiKDs are inflammatory keratinization diseases caused by autoinflammatory-related pathomechanisms in the skin.The aberrant activation of innate immunity and the resultant autoinflammation in the epidermis and the superficial dermis in AiKDs cause hyperkeratosis in the epidermis.Our initially proposed concept of AiKDs included generalized pustular psoriasis and related conditions, pityriasis rubra pilaris type V, and familial keratosis lichenoides chronica.Since then, the number of diseases known to be AiKDs has increased as previously unknown diseasecausing factors and pathogenetic mechanisms of inflammatory keratinization diseases have been clarified one by one.To date, porokeratosis, hidradenitis suppurative, keratosis linearis with ichthyosis congenita and sclerosing keratoderma (KLICK) syndrome, and AiKDs associated with epidermal growth factor receptor (EGFR) deficiency or with hepatitis and autism have been recognized as AiKDs.The concept of AiKDs is considered extremely useful in our precise understanding of the pathogeneses behind inflammatory keratinization diseases and our appropriate treatment method selection.The number of AiKDs is expected to grow with the clarification of the pathomechanisms of further inflammatory keratinization diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inhibition of the Interleukin-36 Pathway for the Treatment of Generalized Pustular Psoriasis
Bachelez, H., Choon, S.-E., Marrakchi, S., Burden, A. D., Tsai, T.-F., Morita, A., Turki, H., Hall, D. B., Shear, M., Baum, P., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmc1811317 · Cited by 292
Mascia, F., Lam, G., Keith, C., Garber, C., Steinberg, S. M., Kohn, E., & Yuspa, S. H. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3005773 · Cited by 105
Haskamp, S., Bruns, H., Hahn, M., Hoffmann, M., Gregor, A., Löhr, S., Hahn, J., Schauer, C., Ringer, M., Flamann, C., et al. (2020) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2020.07.001 · Cited by 84
Cited by
Psychiatric Comorbidities and Schizophrenia
Buckley, P. F., Miller, B. J., Lehrer, D. S., & Castle, D. J. (2009) · Schizophrenia Bulletin · doi:10.1093/schbul/sbn135 · Cited by 1,121
Molecular pathogenesis of malignant mesothelioma
Sekido, Y. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt166 · Cited by 279
Systematic review with meta-analysis: cytokines in fibromyalgia syndrome
Üçeyler, N., Häuser, W., & Sommer, C. (2011) · BMC Musculoskeletal Disorders · doi:10.1186/1471-2474-12-245 · Cited by 260
PI3K/PTEN/Akt and TSC/mTOR signaling pathways, ovarian dysfunction, and infertility: an update
Makker, A., Goel, M. M., & Mahdi, A. A. (2014) · Journal of Molecular Endocrinology · doi:10.1530/jme-14-0220 · Cited by 214
Metadata
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 1964-06-15
- Volume
- 188
- Issue
- 11
- Pages
- 234
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W4256205778
- Cited by
- 181
- References
- 3
- FWCI
- 0.00
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Nagoya Journal of Medical Science. https://app.cochat.ai/papers/10.1001/jama.1964.03060370134082
- The paper
- Nagoya Journal of Medical Science. (1964). JAMA. https://doi.org/10.1001/jama.1964.03060370134082
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.